Skip to content

A clinical study for the treatment of chronic eczema with Wenrun Xinjin Peiben Granules

Eczema intervention study based on the concept lung and spleen are the core of syndrome differentiation of zang-fu-organs that has long-term efficacy advantage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020092
Enrollment
Unknown
Registered
2018-12-14
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic eczema

Interventions

Group 1:wenrunxinjinpeiben granule

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) conform to Western Medicine diagnostic criteria; (2) conform to TCM syndrome diagnosis criteria; (3) the area of skin damage is less than 30%; (4) the age of 18 ~ 70 years old,male or female is not limited; (5) Accept the diagnosis and treatment arrangement of doctors and sign the informed consent voluntarily; (6) The diagnosis must be approved by two dermatologists with intermediate or above professional titles.

Exclusion criteria

Exclusion criteria: (1) patients with seriously primary diseases like cardiovascular, kidney, lung, liver, hematopoietic and mental diseases; (2) patients with poor compliance and be unable to take medicine on time; (3) patients with fungal infection, tumor and other factors; (4) the patients can not self-report or direct caregiver (relatives, nanny, etc.) also unknown condition; (5) pregnants or breast-feeding females; (6) patients who are allergic to experimental drugs; (7) patients who is participating in other drug trials; (8) patients with the history of chronic alcoholism or drug abuse or any other factor that affects compliance; (9) patients has attended the immunomodulator treatment within one month;taken steroid medication within two weeks or taken antihistamine drugs or topical steroid drugs within one week.

Design outcomes

Primary

MeasureTime frame
Eczema area and severity index;Recurrence rate and recurrence frequency;effective rate and cure rate;

Secondary

MeasureTime frame
Eosinophil count;Serum total IgE level;curative effect of TCM syndrome;Dermatology Life Quality Index;

Countries

China

Contacts

Public ContactLi YL

China-Japan Friendship Hospital

lylgyh2000@aliyun.com+86 13801155095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026